atoS Antibody

Datasheet

Code	CSB-PA312324XA01ENV
Size	Enquire
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Escherichia coli (strain K12) atoS Polyclonal antibody

Uniprot No.

Q06067

Target Names

atoS

Alternative Names

atoS; b2219; JW2213; Signal transduction histidine-protein kinase AtoS

Raised in

Rabbit

Species Reactivity

Escherichia coli (strain K12)

Immunogen

A synthesized peptide derived from Escherichia coli (strain K12) atoS protein

Immunogen Species

Escherichia coli (strain K12)

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, Dot blot (guaranteed specific to the immunizing peptide)

Protocols

ELISA Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Value-added Deliverables

①. 100ug * KLH-conjugated peptide paired with 100ug * BSA-conjugated peptide (positive control);
②. 1ml*pre-immune serum (used as negative control) for free;
③. Rabbit polyclonal antibodies purified by Antigen Affinity;

Quality Guarantee

1. CUSABIO guarantees the antibody purity > 95% confirmed by SDS-PAGE.
2. CUSABIO guarantees the antibody titer > 1: 64,000 confirmed by ELISA.
3. CUSABIO guarantees to offer Peptide-specific Dot blot.
4. CUSABIO guarantees 100% risk-free: No qualified antibody, no charge.

Lead Time

Made-to-order (14-16 weeks)

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

Member of the two-component regulatory system AtoS/AtoC. In the presence of acetoacetate, AtoS/AtoC stimulates the expression of the atoDAEB operon, leading to short chain fatty acid catabolism and activation of the poly-(R)-3-hydroxybutyrate (cPHB) biosynthetic pathway. Also induces the operon in response to spermidine. Involved in the regulation of motility and chemotaxis, via transcriptional induction of the flagellar regulon. AtoS is a membrane-associated kinase that phosphorylates and activates AtoC in response to environmental signals.

Gene References into Functions

AtoS is a membrane protein which can autophosphorylate & then transfer that phosphoryl group to AtoC. Gene products of atoS & atoC constitute a 2-component signal transduction system, with some unusual properties, involved in regulation of atoDAEB operon. PMID: 16153782

Subcellular Location

Cell inner membrane; Multi-pass membrane protein.

Database Links

KEGG: ecj:JW2213

STRING: 316385.ECDH10B_2377

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Oncogenes and Cancer Neuronal Markers and Neurodegenerative Diseases Non-Hodgkin's Lymphoma, One of Common Heterogeneous Malignant Tumors TNFRSF9: A Potent Immune-Stimulator in Cancer TNFR1: Elucidating Dual Mechanisms and Evolving as a Precision Therapeutic Target DLL3: A New Molecular Target in Cancer Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy PTPRD: The Overlooked Signaling Hub from Neurodevelopment to Cancer Suppression CLDN9: Another Key Regulator for Tumors or Hearing Loss from the CLDN Family! RSPO1: The key factor determining "battle of the sexes " is “favored” in the culture of organoids? Intestinal Mucosal Barrier Bodyguard --ALPi The Collection of Progress of Anti-GPCR Antibody Drugs Immune Activation: Insights into T Cell Differentiation How to Choose the Loading Control Antibodies? The Overview of Recombinant Antibody Interleukin 4 receptor (IL-4R/IL-4Ra): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research! Normal Growth Hormone Levels But Still Can't Grow Tall? 2026 Latest Research: Perhaps the GH1 Gene Holds Hidden Secrets Focus on Emerging Therapeutic Targets BCMA CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! Tumor Necrosis Factor Receptor Superfamily and Apoptosis Monoclonal Antibody Drugs Overview A groundbreaking breakthrough! Domestic "sandwich" regimen boosts 2-year survival rate to 97% in B-ALL patients, as the CD22 target achieves another success. GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! Unraveling the Dynamic World of Histone Modifications: Implications in Gene Regulation and Disease Pathogenesis The Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in Cancer What Essential Biological Knowledge is Needed for Hepatocellular Carcinoma Research? GPCR Drugs Discovery CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors! Diabetes: What You Need to Know Before Starting Research? PD-1-- An Important Immune Checkpoint Does TNF Superfamily Inhibit Cancer or Promote Its Development? Another powerful addition to domestic IL-17A inhibitors! 3S Guojian's Anmoqitamab approved, with once-every-8-week dosing—a game-changer for psoriasis patients. CD69: a Classical Early Marker of Lymphocyte Activation, a Pivotal Regulator of Hematologic Diseases and Autoimmune Disorders! Itaconate is a negative regulator of inflammation The Overview of Interleukin The "Plaque Cleaner" in Blood Vessels Has Arrived! CD25+ Regulatory T Cells Transform into CAR-Tregs with Amazing Results CXCR4: An Attractive Target of GPCR family Brings Promising New Drugs for Cancer Therapy！ CLDN3: Another Tight Junction Protein or New Drug Target, Interest in CLDN Family is Growing Fast! BDCA2/CLEC4C: a Novel Plasma Cell-Like Dendritic Cell (pDC) Marker and Potent Inhibitor of IFN-I that Blocks SLE Development! SEMA4D/CD100: As an Important Immunoregulator to Improve Immunotherapy SSTR2: A Prominent Target in SSTR Family, Offers a More Precise Therapy in Neuroendocrine Tumors (NET) CNR1 (CB1): A Crucial Receptor of Endocannabinoid System Offers Potential Treatments for Tumors and Glycolipid Metabolism Disorders! DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)! MAGEA4: a Member of the Melanoma-Associated Antigen (MAGE) Family, a Popular Target for Tumor-Specific Immune Research! Exploring Protein-Protein Interactions: A Comprehensive Guide to Understanding and Utilizing It TIGIT Targeted Immunotherapies Offer New Hope for Cancer Treatment CD79A and CD79B: Key Targets in B Cell Signaling Pathways and Therapeutic Potential The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug Development CSF2/GM-CSF: A Key Molecule in Immune Regulation and Disease Treatment TNFSF18: Unlocking New Frontiers in Cancer Immunotherapy IL-6: A Central Factor in Cytokine Storms and a Health Alert for Infections and Diseases TNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease Treatment IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion CCL17: A Chemokine with Multiple Biological Functions Immune Battlefield's "Scout": Decoding the NCR3 Target FLT1 (VEGFR-1): A Bidirectional Regulator of Angiogenesis and an Emerging Therapeutic Target CD45: The Immune Cell "Gatekeeper" Protein – Why is it Emerging as a Novel Therapeutic Target? Targeting TNFRSF13B: Dual-Target Strategies Usher in New Focus for Treating Tumors and Autoimmune Diseases In-depth Dialogue on the "Core Triangle" of Inflammation: How IL-6, IL-1β, and TNF-α Interact to Drive Disease Progression? GPR20: From "Orphan" to a Promising Novel Target for Overcoming Drug-Resistant GIST BTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune Diseases PDGFRA: A Hub in Cellular Signaling and a Therapeutic Target Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLA Spanning Eight Major Cancers: Why Has Transmembrane Mucin MUC13 Become a New Focus in Precision Tumor Therapy? CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy Overview of CCR4 Target: Core Roles in Physiological Functions and Pathological Regulation CD28: Molecular Mechanism and Therapeutic Progress of the Core Co-Stimulatory Receptor in T Cells CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development CD19: Molecular Mechanisms, Disease Associations and Progress in Targeted Therapy CD40LG: A Key Molecule in Immune Regulation, Disease Associations and Therapeutic Progress CD74: From MHC II Chaperone to Therapeutic Target - Molecular Mechanisms, Disease Associations and Therapeutic Advances The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune Homeostasis Beyond PD-1/CTLA-4! The Emerging Immune Checkpoint CD160 is Transforming the Landscape of Tumor Immunotherapy Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
Please enter the characters shown. Click the image to refresh if unclear.

atoS Antibody

Product Details

Related Products

Customer Reviews and Q&A

Target Background